Foreground Capital is a venture capital firm investing in early-stage women's health companies across biopharma, devices, diagnostics, digital health, and tech-enabled services. Launched in 2024, the firm continues to manage the legacy RH Capital Funds I and II.
33% of their portfolio is in Healthcare. Their most common stage is series-a (50% of deals). Average disclosed round size is $16.2M (across 5 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Eli Health | Series A | $17M | Jun 2025 |
 Millie | Series A | $12M | Feb 2025 |
 Millie | Series A | $12M | Jan 2025 |
 Gesynta Pharma | Series B | — | Jan 2025 |
 SimpliFed | Unknown | $10M | — |
| GGreg | Unknown | $30M | — |
Top Co-Investors
Amboy Street Ventures3 shared
TMV2 shared
BBG Ventures2 shared
Joyance Partners2 shared
Pivotal Ventures2 shared
LearnStart2 shared
Ingeborg Investments2 shared
Korea Investment Partners1 shared
Stephen Industries1 shared
Industrifonden1 shared
HealthCap1 shared
Innovestor1 shared
Hadean Ventures1 shared
NEXTBLUE1 shared
Real Ventures1 shared
TELUS Global Ventures1 shared
Muse Capital1 shared
Swizzle Ventures1 shared
Garage Capital1 shared
Last updated: 20 October 2026